177 related articles for article (PubMed ID: 6285699)
1. Acyclovir treatment of experimental genital herpes simplex virus infections.
Kern ER
Am J Med; 1982 Jul; 73(1A):100-8. PubMed ID: 6285699
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir treatment of experimental genital herpes simplex virus infections. I. Topical therapy of type 2 and type 1 infections of mice.
Kern ER; Richards JT; Overall JC; Glasgow LA
Antiviral Res; 1983 Nov; 3(4):253-67. PubMed ID: 6320718
[TBL] [Abstract][Full Text] [Related]
3. Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig.
Landry ML; Lucia HL; Hsiung GD; Pronovost AD; Dann PR; August MJ; Mayo DR
Am J Med; 1982 Jul; 73(1A):143-50. PubMed ID: 6285705
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs.
Bravo FJ; Stanberry LR; Kier AB; Vogt PE; Kern ER
Antiviral Res; 1993 May; 21(1):59-72. PubMed ID: 8391249
[TBL] [Abstract][Full Text] [Related]
5. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
Park NH; Pavan-Langston D; McLean SL; Lass JH
Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
[TBL] [Abstract][Full Text] [Related]
6. Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs.
Richards JT; Kern ER; Overall JC; Glasgow LA
Antiviral Res; 1982 May; 2(1-2):27-39. PubMed ID: 6179469
[TBL] [Abstract][Full Text] [Related]
7. Effect of acyclovir on genital herpes in guinea pigs.
Pronovost AD; Lucia HL; Dann PR; Hsiung GD
J Infect Dis; 1982 Jun; 145(6):904-8. PubMed ID: 6282986
[TBL] [Abstract][Full Text] [Related]
8. Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice.
Collins P; Oliver NM
Am J Med; 1982 Jul; 73(1A):96-9. PubMed ID: 7102714
[TBL] [Abstract][Full Text] [Related]
9. Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections.
Corey L; Benedetti JK; Critchlow CW; Remington MR; Winter CA; Fahnlander AL; Smith K; Salter DL; Keeney RE; Davis LG; Hintz MA; Connor JD; Holmes KK
Am J Med; 1982 Jul; 73(1A):326-34. PubMed ID: 7048919
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections.
Sheridan J; Kern E; Martin A; Booth A
Antiviral Res; 1997 Dec; 36(3):157-66. PubMed ID: 9477116
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the antiherpetic activity of acyclovir in rabbits.
Trousdale MD; Nesburn AB
Am J Med; 1982 Jul; 73(1A):155-60. PubMed ID: 6285707
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topical acyclovir monophosphate, acyclovir, or penciclovir in orofacial HSV-1 infections of mice and genital HSV-2 infections of guinea pigs.
Kern ER; Palmer J; Szczech G; Painter G; Hostetler KY
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):501-13. PubMed ID: 10772730
[TBL] [Abstract][Full Text] [Related]
13. Failure of 2-deoxy-D-glucose in the treatment of experimental cutaneous and genital infections due to herpes simplex virus.
Kern ER; Glasgow LA; Klein RJ; Friedman-Kien AE
J Infect Dis; 1982 Aug; 146(2):159-66. PubMed ID: 6286785
[TBL] [Abstract][Full Text] [Related]
14. Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit.
Spruance SL; Crumpacker CS
Am J Med; 1982 Jul; 73(1A):315-9. PubMed ID: 6285721
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B
J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738
[TBL] [Abstract][Full Text] [Related]
16. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
Sibrack CD; McLaren C; Barry DW
Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpes.
Jennings R; Smith TL; Myhren F; Phillips J; Sandvold ML
Antimicrob Agents Chemother; 1999 Jan; 43(1):53-61. PubMed ID: 9869565
[TBL] [Abstract][Full Text] [Related]
18. Oral and topical treatment of experimental HSV-1 genital herpes with (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Sim IS
J Antimicrob Chemother; 1984 Aug; 14 Suppl A():111-8. PubMed ID: 6541647
[TBL] [Abstract][Full Text] [Related]
19. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
Kern ER; Richards JT; Overall JC; Glasgow LA
Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
[TBL] [Abstract][Full Text] [Related]
20. Topical butylated hydroxytoluene treatment of genital herpes simplex virus infections of guinea pigs.
Richards JT; Katz ME; Kern ER
Antiviral Res; 1985 Oct; 5(5):281-90. PubMed ID: 2998276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]